Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$2.49M+66.8%-$7.51M+54.5%-$16.5M+3.0%-$17.01M+13.2%-$19.59M-48.6%
$1.62M-1.0%$1.63M-5.3%$1.72M-4.5%$1.81M+1.2%$1.78M+4.5%
$1.69M+28.0%$1.32M+28.6%$1.02M+36.2%$752K-48.4%$1.46M+13.1%
-$2.22M-$12.63M-23.8%-$10.2M-105%-$4.99M-225%
$1.04M-1.7%$1.06M+75.5%$604K-50.0%$1.21M+268%$328K-81.3%
-$1.04M+1.7%-$1.06M-75.5%-$604K+50.0%-$1.21M-498%-$202K
$0$20M
-$28K-101%$3.73M-64.8%$10.6M+440%$1.96M+141%-$4.74M-2,790%
-$3.29M-$2.63M+72.1%-$9.45M+4.9%-$9.93M-538%
-$3.26M$0+100%-$13.23M-16.0%-$11.41M-115%-$5.32M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does The Oncology Institute, Inc. generate?
The Oncology Institute, Inc. (TOI) generated -$30.0M in operating cash flow over the trailing twelve months.
What is The Oncology Institute, Inc.'s free cash flow?
After $3.9M of capital expenditures, The Oncology Institute, Inc.'s free cash flow was -$27.9M over the trailing twelve months, up 36.7% year over year.
Where does The Oncology Institute, Inc.'s cash flow data come from?
Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.